Neuphoria Therapeutics, Inc. (NEUP)
3.06
-0.30
(-8.93%)
USD |
NASDAQ |
Oct 29, 16:00
3.10
+0.04
(+1.31%)
After-Hours: 05:04
Neuphoria Therapeutics Total Assets (Quarterly) : 28.71M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.71M |
| March 31, 2026 | 34.81M |
| December 31, 2025 | 36.60M |
| September 30, 2025 | 27.34M |
| Date | Value |
|---|---|
| March 31, 2025 | 30.71M |
| December 31, 2024 | 18.17M |
| September 30, 2024 | 22.92M |
| June 30, 2024 | 27.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.109M |
| Shareholders Equity (Quarterly) | 24.60M |
| Debt to Equity Ratio | 0.0014 |
| Current Ratio | 27.85 |
| Net Debt Paydown Yield | 0.11% |